Industry

DALLAS–(BUSINESS WIRE)–#Digitalhealth—Recuro Health (Recuro), a premier virtual health solutions company that takes a uniquely personalized and proactive approach to virtual care through its Digital Medical Home™ (DMH), today announces the acquisition of Competitive Health (CHI), an integrated digital health solutions company that provides a suite of digital products to help employers reduce costs, promote engagement … [Read more…]

Company expanding micro-fine glass fiber capacity in US, Europe, and China to support future growth BUFFALO, N.Y.–(BUSINESS WIRE)–Alkegen, one of the largest specialty materials platforms in the world that provides high performance materials used in advanced applications including filtration media, battery technologies, high temperature insulation and fire protection, today announced expansion efforts aimed at increasing … [Read more…]

Novel NMR Probe Technologies, GHz-class NMR and Dynamics Software Enable New Research, and Advance Functional Structural Biology and Drug Discovery BOSTON–(BUSINESS WIRE)–$BRKR #BRKR–At the ICMRBS 2022 Conference, Bruker today announces a new 8 mm 15N TROSY Cryoprobe for enabling novel NMR functional structural biology investigations into larger globular proteins and protein complexes. The new technology … [Read more…]

Presentation by study’s co-author Dr. Kim Papp, a Key Opinion Leader who has completed over 150 studies and worked on numerous drugs now on the market Dr. Papp is designing Can-Fite’s pivotal Phase III psoriasis registration trial PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of … [Read more…]

A review decision by the European Medicines Agency (EMA) is expected in the second half of 2023 If approved, sparsentan will be a first-in-class treatment to address the significant unmet medical need in IgA nephropathy (IgAN) in Europe ST. GALLEN, Switzerland & SAN DIEGO–(BUSINESS WIRE)–CSL Vifor and Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that … [Read more…]

LAVAL, Quebec–(BUSINESS WIRE)–BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough (“RCC”) and other cough hypersensitivity indications, today announced that three abstracts reviewing clinical data from the Phase 2b SOOTHE trial will be presented at the upcoming European Respiratory Society … [Read more…]

– Highly-accurate, tissue-based, next-generation sequencing (NGS) test approved in China as a companion diagnostic for targeted colon cancer therapies NATICK, Mass.–(BUSINESS WIRE)–Pillar Biosciences, the leader in Decision Medicine™, developers and distributors of next-generation sequencing (NGS) tests which localize testing and reduce time to treatment initiation and overall testing costs, today announced that its oncoRevealTM Dx … [Read more…]

Omnipod 5 is the first tubeless AID System cleared in the U.S. for preschool children ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for its … [Read more…]

The Carl F. Braun Trust awards Children’s Hospital Los Angeles $1.92 million to conduct research on integrative techniques to alleviate pain in children. LOS ANGELES–(BUSINESS WIRE)–Children’s Hospital Los Angeles has received a gift of $1.92 million from the Carl F. Braun Trust to support a three-year research study to measure the impact of using integrative … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Otoscopes – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Otoscopes Market to Reach $198.1 Million by 2026 The global market for Otoscopes estimated at US$172.8 Million in the year 2022, is projected to reach a revised size of US$198.1 Million by 2026, growing at a CAGR of … [Read more…]